M. Salton
Molecular Biology · 2011–2015
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 18 citations into it
Whom M. Salton trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from M. Salton's perspective
Ordered by how strongly the researchers M. Salton trusts endorse each paper. Same corpus, a different order for every researcher.
- Epigenetics in alternative pre-mRNA splicing (Cell)
- The spliceosome: design principles of a dynamic RNP machine. (Cell)
- Alternative splicing: increasing diversity in the proteomic world. (Trends in Genetics)
- The RAF proteins take centre stage (Nature reviews. Molecular cell biology)
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma (New England Journal of Medicine)
- RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth (Nature)
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF (Cell)
- Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by co-targeting MEK and IGF-1R/PI3K (Cancer Cell)
- RAF inhibitors transactivate RAF dimers and ERK signaling in cells with wild-type BRAF (Nature)
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation (Nature)
Their papers
- RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E) (2011) — 1,402 citations
- Small molecule modulators of pre-mRNA splicing in cancer therapy (2015) — 143 citations